Empowered Patient Podcast

Harrison Brown Co-Founder and CEO, HeadCheck Health wants to make it easy to better identify, diagnose, manage and clear people who have suffered from a concussion to allow them to resume their regular activities. While sports teams and other organizations have developed a concussion protocol for managing those who suffer from a head injury, most often the rules are not followed. Patients and athletes are often asked if they have suffered a concussion and HeadCheck wants to provide baseline information as well as indicators of those most at risk for suffering another concussion to assist healthcare providers make more informed decisions.

@HeadCheckHealth #concussions #concussion #health #digitalhealth #mhealth

HeadCheckHealth.com

Listen to the podcast here

Harrison Brown Co-Founder and CEO, HeadCheck Health wants to make it easy to better identify, diagnose, manage and clear people who have suffered from a concussion to allow them to resume their regular activities. While sports teams and other organizations have developed a concussion protocol for managing those who suffer from a head injury, most often the rules are not followed. Patients and athletes are often asked if they have suffered a concussion and HeadCheck wants to provide baseline information as well as indicators of those most at risk for suffering another concussion to assist healthcare providers make more informed decisions.

@HeadCheckHealth #concussions #concussion #health #digitalhealth #mhealth

HeadCheckHealth.com

Download the transcript here

Dr. Jay Anders, Chief Medical Officer, Medicomp Systems addresses how COVID-19 has revealed weaknesses in the US healthcare system and the need to address the challenges from the lack of interoperability and accurate point-of-care information. With an eye to the use of artificial intelligence and remembering that the smartest computer in an exam room sits between the physician's ears, Jay sees many opportunities for AI to make patient health data actionable.

@medicompsys #COVID19 #AI #DigitalHealth

Medicomp.com

Listen to the podcast here.

Dr. Jay Anders, Chief Medical Officer, Medicomp Systems addresses how COVID-19 has revealed weaknesses in the US healthcare system and the need to address the challenges from the lack of interoperability and accurate point-of-care information. With an eye to the use of artificial intelligence and remembering that the smartest computer in an exam room sits between the physician's ears, Jay sees many opportunities for AI to make patient health data actionable.

@medicompsys #COVID19 #AI #DigitalHealth

Medicomp.com

Download the transcript here.

Chris Bradley, CEO and Co-Founder, Loki Therapeutics talks about a new generation of cancer immune therapy that takes advantage of the body's ability to fight antigens it already recognizes from a previous childhood vaccination. The delivery mechanism uses an attenuated bacteria listeria monocytogenes that colonizes the tumor and triggers the body's immune system through naive T cells. Early data is showing effectiveness for advanced metastatic pancreatic cancer and advanced metastatic ovarian cancer with potential for treating other solid tumors.

#LokiTherapeutics #MemoryTCells #immunotherapy #ovariancancer #pancreaticCancer #Cancer

LokiTX.com

Listen to the podcast here.

Chris Bradley, CEO and Co-Founder, Loki Therapeutics talks about a new generation of cancer immune therapy that takes advantage of the body's ability to fight antigens it already recognizes from a previous childhood vaccination. The delivery mechanism uses an attenuated bacteria listeria monocytogenes that colonizes the tumor and triggers the body's immune system through naive T cells. Early data is showing effectiveness for advanced metastatic pancreatic cancer and advanced metastatic ovarian cancer with potential for treating other solid tumors.

#LokiTherapeutics #MemoryTCells #immunotherapy #ovariancancer #pancreaticCancer #Cancer

LokiTX.com

Download the transcript here

Dr. David Mayer, CEO, Patient Safety Movement Foundation is an advocate for awareness of preventable medical harm in healthcare and steps that need to be taken to keep both patients and healthcare workers safe. With a focus on transparency to allow patients to make informed decisions, Dave emphasizes the need to address gaps in quality and safety data. To inform a larger audience about World Patient Safety Day September 17, Dave is virtually walking across the country and has attracted an international team to walk and run with him through the use of the app Charity Miles.

@plan4zero @WalkforPTSafety #uniteforsafecare

UniteForSafeCare.org

Listen to the podcast here.

Dr. David Mayer, CEO, Patient Safety Movement Foundation is an advocate for awareness of preventable medical harm in healthcare and steps that need to be taken to keep both patients and healthcare workers safe. With a focus on transparency to allow patients to make informed decisions, Dave emphasizes the need to address gaps in quality and safety data. To inform a larger audience about World Patient Safety Day September 17, Dave is virtually walking across the country and has attracted an international team to walk and run with him through the use of the app Charity Miles.

@plan4zero @WalkforPTSafety #uniteforsafecare

UniteForSafeCare.org

Download the transcript here.

Dr. Tim Rodell, Chief Executive Officer, Aethlon Medical brings us up to speed on the work at Aethlon in developing immunotherapeutic technologies using their Hemopurifier to clear a virus as well as exosomes in patients with cancer as blood flows through the nanofibers of the Hemopurifier cartridge. With more recent understanding of the role of exosomes in the spread of cancer, Aethlon is exploring the advantage of adding treatment with Hemopurifier to make more patients respond to Keytruda. With an Investigational Device Exemption (IDE) from the FDA, Aethlon is opening clinical trials on treating COVID-19 with Hemopurifier to remove the SARS-CoV-2 COVID virus from the circulation.

@aethlon_medical #immunotherapy #cancer #exosomes #Infectiousdiseases #COVID19

AethlonMedical.com

Listen to the podcast here.

Dr. Tim Rodell, Chief Executive Officer, Aethlon Medical brings us up to speed on the work at Aethlon in developing immunotherapeutic technologies using their Hemopurifier to clear a virus as well as exosomes in patients with cancer as blood flows through the nanofibers of the Hemopurifier cartridge. With more recent understanding of the role of exosomes in the spread of cancer, Aethlon is exploring the advantage of adding treatment with Hemopurifier to make more patients respond to Keytruda. With an Investigational Device Exemption (IDE) from the FDA, Aethlon is opening clinical trials on treating COVID-19 with Hemopurifier to remove the SARS-CoV-2 COVID virus from the circulation.

@aethlon_medical #immunotherapy #cancer #exosomes #Infectiousdiseases #COVID19

AethlonMedical.com

Download the transcript here.